CN101132693B - 用于控制过度增生性皮肤病的组合物以及方法 - Google Patents

用于控制过度增生性皮肤病的组合物以及方法 Download PDF

Info

Publication number
CN101132693B
CN101132693B CN2004800436759A CN200480043675A CN101132693B CN 101132693 B CN101132693 B CN 101132693B CN 2004800436759 A CN2004800436759 A CN 2004800436759A CN 200480043675 A CN200480043675 A CN 200480043675A CN 101132693 B CN101132693 B CN 101132693B
Authority
CN
China
Prior art keywords
composition
psoriasis
boswellic acid
selenomethionine
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2004800436759A
Other languages
English (en)
Chinese (zh)
Other versions
CN101132693A (zh
Inventor
穆罕麦德·马吉德
萨巴拉克什米·普拉卡什
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Original Assignee
Sami Chemicals and Extracts Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/710,778 external-priority patent/US7582314B2/en
Application filed by Sami Chemicals and Extracts Ltd filed Critical Sami Chemicals and Extracts Ltd
Publication of CN101132693A publication Critical patent/CN101132693A/zh
Application granted granted Critical
Publication of CN101132693B publication Critical patent/CN101132693B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
CN2004800436759A 2004-08-02 2004-10-14 用于控制过度增生性皮肤病的组合物以及方法 Expired - Fee Related CN101132693B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/710,778 US7582314B2 (en) 2003-12-03 2004-08-02 Compositions and methods for the management of hyperproliferative dermatological conditions
US10/710,778 2004-08-02
PCT/US2004/033846 WO2006022762A1 (en) 2004-08-02 2004-10-14 Compositions and methods for the management of hyperproliferative dermatological conditions

Publications (2)

Publication Number Publication Date
CN101132693A CN101132693A (zh) 2008-02-27
CN101132693B true CN101132693B (zh) 2012-11-07

Family

ID=35967805

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800436759A Expired - Fee Related CN101132693B (zh) 2004-08-02 2004-10-14 用于控制过度增生性皮肤病的组合物以及方法

Country Status (12)

Country Link
EP (1) EP1791423B1 (enExample)
JP (1) JP4820819B2 (enExample)
CN (1) CN101132693B (enExample)
AU (1) AU2004322710B2 (enExample)
DK (1) DK1791423T3 (enExample)
ES (1) ES2422893T3 (enExample)
NZ (1) NZ552027A (enExample)
PL (1) PL1791423T3 (enExample)
PT (1) PT1791423E (enExample)
RU (1) RU2366412C2 (enExample)
WO (1) WO2006022762A1 (enExample)
ZA (1) ZA200700694B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010029578A2 (en) * 2008-09-15 2010-03-18 Ganga Raju Gokaraju Synergistic anti-inflammatory compositions comprising boswellia serrata extracts
ITVR20080125A1 (it) * 2008-11-13 2010-05-14 Phytonature Sas Di Masini Dr Antoni O E C Nuova forma di preparazione ed utilizzo della boswellia serrata
WO2011099029A1 (en) * 2010-02-15 2011-08-18 Laila Nutraceuticals A novel boswellia low polar gum resin extract and its synergistic compositions
US20110218172A1 (en) * 2010-03-02 2011-09-08 Muhammed Majeed Composition for down-regulating pro-inflammatory markers
CN102670565A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种含天然药物的透皮吸收贴片
CN102670690A (zh) * 2011-03-14 2012-09-19 苏州博创园生物医药科技有限公司 一种抗牛皮癣纯天然药物乳膏及其制备方法
CN103193853A (zh) * 2012-01-06 2013-07-10 苏州博创园生物医药科技有限公司 用于治疗银屑病的化合物、组合物及其制备方法
US9498423B2 (en) * 2012-05-07 2016-11-22 Sami Labs Limited Synergistic selenopeptide formulations for the protection of dermal papilla cells
CA3020713A1 (en) * 2016-04-19 2017-10-26 Azura Ophthalmics Ltd. Compositions for the treatment of hyperkeratosis disorders
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
EP4087655A4 (en) 2020-01-10 2024-02-21 Azura Ophthalmics Ltd INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY
EP4295842A1 (en) 2022-06-24 2023-12-27 Faaborg Pharma - IP ApS A skin care composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3670084A (en) * 1969-06-20 1972-06-13 Leopoldo F Montes Method of treating psoriasis with cycloheximide
US5536506A (en) * 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
CN1233482A (zh) * 1998-04-28 1999-11-03 山东省滨州卫生学校 富硒灵芝在治疗银屑病的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
DE4445728A1 (de) * 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
RU2152218C1 (ru) * 1998-04-21 2000-07-10 Дальневосточный государственный медицинский университет Способ лечения псориаза
US6399105B1 (en) * 1999-01-20 2002-06-04 Peter Donald Collin Sea cucumber carotenoid lipid fraction products and methods of use
EP1173162A1 (en) * 1999-04-30 2002-01-23 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
GB0230203D0 (en) * 2002-12-27 2003-02-05 Domantis Ltd Fc fusion
KR20050090435A (ko) * 2002-12-30 2005-09-13 셀진 코포레이션 플루오로알콕시-치환된 1,3-디히드로-이소인돌릴 화합물 및그의 제약학적 용도

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3670084A (en) * 1969-06-20 1972-06-13 Leopoldo F Montes Method of treating psoriasis with cycloheximide
US5536506A (en) * 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
CN1233482A (zh) * 1998-04-28 1999-11-03 山东省滨州卫生学校 富硒灵芝在治疗银屑病的药物中的应用

Also Published As

Publication number Publication date
RU2007102720A (ru) 2008-09-10
DK1791423T3 (da) 2013-08-05
WO2006022762B1 (en) 2006-05-04
RU2366412C2 (ru) 2009-09-10
JP4820819B2 (ja) 2011-11-24
WO2006022762A1 (en) 2006-03-02
EP1791423B1 (en) 2013-05-01
CN101132693A (zh) 2008-02-27
EP1791423A1 (en) 2007-06-06
ZA200700694B (en) 2007-11-28
JP2008508354A (ja) 2008-03-21
PL1791423T3 (pl) 2013-09-30
ES2422893T3 (es) 2013-09-16
AU2004322710B2 (en) 2011-03-31
AU2004322710A1 (en) 2006-03-02
EP1791423A4 (en) 2009-06-17
PT1791423E (pt) 2013-08-02
NZ552027A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
ZA200700694B (en) Compositions and methods for the management of hyperproliferative dermatological conditions
US8057825B2 (en) Krill extracts for treatment of cardiovascular diseases
RU2671492C2 (ru) Композиции, содержащие берберин или его аналоги для лечения кожных заболеваний, связанных с розацеа или с покраснением лица
US7582314B2 (en) Compositions and methods for the management of hyperproliferative dermatological conditions
US20220233627A1 (en) Compositions comprising plant extracts and oils and related methods of treatment and their preparation
Sukare et al. Herbal plant used in treatment of psoriasis-a systematic review
Krishnakumar et al. Efficacy and safety of a proprietary Punica granatum extract in skin health-a randomized, placebo-controlled clinical study in healthy volunteers
Natarelli et al. Topical integrative approaches to vitiligo: A systematic review
BEHANDLUNG et al. DERMATOLOGICAL CONDITIONS
US8147851B2 (en) Treating eczema and/or psoriasis
Mohammed et al. Natural Remedies for the Skin Conditions of Eczema, Psoriasis, and Vitiligo: In-Depth Exploration and Development of an Effective Treatment Plan
Yun A Case of Improvement of Photosensitivity Allergy Using Ortho-Cellular Nutrition Therapy (OCNT)
JP2026506380A (ja) 皮膚の状態または疾患を処置する方法
TW202335679A (zh) 山竹果殼萃取物用於製備促進糖尿病傷口癒合的藥物的用途
RU2171683C1 (ru) Средство для лечения псориаза (варианты) и способ его лечения
Kumar A Study to Evaluate the Efficacy of Aloe Vera in Wound Healing of Post Extraction Socket in Diabetic Subjects
WO2014197129A2 (en) Compositions and methods for treatment and management of pain
HK1126957B (en) Krill extracts for prevention and/or treatment of cardiovascular diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121107